Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Combination Therapy With Carfilzomib, Romidepsin, Lenalidomide in Patients With Relapsed or Refractory B- and T-cell Lymphomas

Phase 1

Completed

Conditions: T-cell Lymphomas
Relapsed or Refractory

Interventions: Drug: Carfilzomib
Drug: Romidepsin
Drug: Lenalidomide

First Posted Date: 2015-01-19

Last Posted Date: 2024-04-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 27

Registration Number: NCT02341014

Locations: 🇺🇸
Memorial Sloan Kettering at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States

and more 3 locations

Endoscopic Biliary Co-axial Stent Placement Plus/Minus Use of Radiofrequency Ablation (RFA) for Clearance of Occluded Self Expandable Metal Stents (SEMS) in Patients With Distal Biliary Obstruction From Unresectable Biliary-pancreatic Malignancies

Phase 3

Completed

Conditions: Pancreatic Cancer
Unresectable Biliary-pancreatic Malignancies

Interventions: Device: ERCP with SEMS alone (standard of care)
Device: ERCP with SEMS plus radiofrequency ablation

First Posted Date: 2015-01-19

Last Posted Date: 2020-10-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT02340728

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Randomized Study Comparing Local Tumor Control After Post-Operative Single-Fraction or Hypofractionated Stereotactic Radiosurgery in the Treatment of Spinal Metastases

Phase 3

Completed

Conditions: Spinal Metastases

Interventions: Radiation: single-fraction SRS
Radiation: high-dose hypofractionated SRS
Behavioral: Quality of Life Measures

First Posted Date: 2014-12-19

Last Posted Date: 2019-02-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 16

Registration Number: NCT02320825

Locations: 🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
John Hopkins Medical Center, Baltimore, Maryland, United States

and more 1 locations

Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)

Phase 1

Recruiting

Conditions: Adult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL)
Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Interventions: Drug: Ibrutinib
Drug: HD- Methotrexate (MTX)
Drug: Rituximab + HD- Methotrexate (MTX)
Drug: procarbazine

First Posted Date: 2014-12-11

Last Posted Date: 2025-04-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 109

Registration Number: NCT02315326

Locations: 🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy

Phase 2

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Device: multi-parametric MRI(MP-MRI)
Device: dynamic contrast-enhanced MRI (DCE)
Procedure: biopsy

First Posted Date: 2014-12-09

Last Posted Date: 2024-10-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 120

Registration Number: NCT02312401

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

and more 5 locations

Comparison of Whole Breast Screening Ultrasound and Contrast Enhanced Mammography for Supplemental Breast Cancer Screening

Completed

Conditions: Breast Cancer Screening

Interventions: Device: contrast enhanced digital mammography (CEDM)
Device: whole breast screening ultrasound (WBUS)

First Posted Date: 2014-12-08

Last Posted Date: 2025-03-28

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 487

Registration Number: NCT02310698

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Ibrutinib in Relapsed and Refractory T-cell Lymphoma

Phase 1

Completed

Conditions: T-cell Lymphoma
Relapsed and Refractory T-cell Lymphoma

Interventions: Drug: Ibrutinib

First Posted Date: 2014-12-05

Last Posted Date: 2023-05-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 14

Registration Number: NCT02309580

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States

Ribavirin for Patients With Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

Not Applicable

Completed

Conditions: Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
Human Papillomavirus (HPV)-Related Malignancies

Interventions: Drug: Ribavirin

First Posted Date: 2014-12-04

Last Posted Date: 2023-01-05

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 12

Registration Number: NCT02308241

Locations: 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States

and more 3 locations

PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study

Not Applicable

Active, not recruiting

Conditions: Neuroblastoma
Melanoma
Sarcoma

Interventions: Biological: 124I-Humanized 3F8

First Posted Date: 2014-12-04

Last Posted Date: 2024-12-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7

Registration Number: NCT02307630

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Yoga Practice for Breast or Ovarian Cancer Patients

Not Applicable

Completed

Conditions: Ovarian Cancer
Breast Cancer

Interventions: Other: Vigorous yoga practice
Other: Restorative (gentle) yoga practice

First Posted Date: 2014-12-02

Last Posted Date: 2019-03-14

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 39

Registration Number: NCT02305498

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy